Orally delivered resveratrol-loaded lipid-core nanocapsules ameliorate LPS-induced acute lung injury via the ERK and PI3K/Akt pathways

BACKGROUND: Resveratrol (RSV) has attracted interest as an alternative drug for the treatment of acute lung injury (ALI) and other pulmonary diseases, but its poor oral bioavailability is a limitation. In this study, we employed drug delivery nanotechnology to improve the stability, lung localizatio...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Nanomedicine
Main Authors: de Oliveira, Maria Talita Pacheco, de Sá Coutinho, Diego, Tenório de Souza, Éverton, Stanisçuaski Guterres, Sílvia, Pohlmann, Adriana Raffin, Silva, Patricia Machado Rodrigues, Martins, Marco Aurélio, Bernardi, Andressa
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6636190/
https://ncbi.nlm.nih.gov/pubmed/31371957
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S200666
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares